Synapse Open Synapse
Science

Domain-alteration chimeras rewire oncogenic complexes in prostate cancer

Nature News · · 54 min read

A novel therapeutic modality enforces non-native androgen receptor (AR)–p300/CBP interactions to collapse AR transcriptional programs, producing super-inhibitory, lineage-selective suppression of metastatic prostate cancer and establishing domain-alteration chimeras as a broadly applicable therapeutic strategy leveraging induced proximity.

Latest from Nature News